Alexander Goodacre

Alexander Goodacre has experience in various roles in the fields of molecular biology, phage display technology, logistics, and dermatology research. Alexander has a PhD in molecular biology and worked as a research assistant at King's College London and as a phage display scientist at Alchemab Therapeutics Ltd. Alexander has also worked as a business analyst at Stolt-Nielsen Limited, where they streamlined logistics processes. Alexander currently holds the position of Phage Display Scientist at Epsilogen Ltd. Alexander is committed to discovering novel treatment options for various diseases through collaborative research.

Alexander Goodacre started their higher education at Birkbeck, University of London in 2013 where they received a Bachelor of Science in Biomedical Sciences, General in 2016. In 2016, they attended UCL and obtained a Master of Science in Genetics in 2017. Currently, they are pursuing a Doctor of Philosophy in Pharmacology at the University of Cambridge, which they are expected to complete by 2023.